Nantahala Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Nantahala Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,123,671	Closed	-$21.5M	–	147
2020 Q4	$21.5M	Buy	5,123,671 +57,716	+1%	+$222K	0.67%	40
2020 Q3	$18.9M	Buy	5,065,955 +62,324	+1%	+$265K	0.58%	38
2020 Q2	$21.8M	Hold	5,003,631	–	–	0.66%	36
2020 Q1	$19M	Buy	5,003,631 +157,464	+3%	+$774K	0.71%	30
2019 Q4	$30.6M	Hold	4,846,167	–	–	0.94%	29
2019 Q3	$20.4M	Buy	4,846,167 +260,900	+6%	+$1.11M	0.76%	35
2019 Q2	$21.3M	Buy	4,585,267 +1,850,000	+68%	+$8.61M	0.66%	38
2019 Q1	$14.5M	Buy	2,735,267 +1,700	+0.1%	+$7.76K	0.45%	43
2018 Q4	$10.1M	Buy	2,733,567 +1,066,900	+64%	+$3.75M	0.31%	53
2018 Q3	$4.67M	Buy	+1,666,667	New	+$4.68M	0.13%	76

Other funds holding BDSI

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nantahala Capital Management's BDSI Position: Q1 2021 in Review

Nantahala Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 5,123,671 shares — an estimated $21.5M sold.

Nantahala Capital Management first reported a position in BDSI in Q3 2018 and held it in 10 quarters. The position peaked at $30.6M in Q4 2019. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

Nantahala Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
Nantahala Capital Management sold 5,123,671 BioDelivery Sciences International, Inc. shares in Q1 2021, an estimated $21.5M.
Nantahala Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2018 and held it in 10 quarters.
Nantahala Capital Management's BioDelivery Sciences International, Inc. position peaked at $30.6M in Q4 2019.
151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on Nantahala Capital Management's 13F filing for Q1 2021, filed 14 May 2021.